Citi Sticks to Its Buy Rating for Super Retail Group Limited (SUL)
In a report released today, Adrian Lemme from Citi maintained a Buy rating on Super Retail Group Limited (SUL – Research Report), with a price target of A$18.00.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
According to TipRanks, Lemme is ranked #1373 out of 9472 analysts.
Currently, the analyst consensus on Super Retail Group Limited is a Moderate Buy with an average price target of A$15.36.
The company has a one-year high of A$18.40 and a one-year low of A$12.06. Currently, Super Retail Group Limited has an average volume of 764K.
Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SUL in relation to earlier this year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen
In a report released yesterday, Josh Jennings from TD Cowen reiterated a Buy rating on PROCEPT BioRobotics (PRCT – Research Report). The company's shares closed yesterday at $65.05. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Jennings covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Medtronic, and Establishment Labs Holdings. According to TipRanks, Jennings has an average return of 4.6% and a 52.11% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for PROCEPT BioRobotics with a $80.20 average price target. PRCT market cap is currently $3.32B and has a P/E ratio of -36.24. Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PRCT in relation to earlier this year. Most recently, in March 2025, Reza Zadno, the President & CEO of PRCT sold 5,475.00 shares for a total of $312,403.50.
Business Insider
2 hours ago
- Business Insider
Stifel Nicolaus Keeps Their Buy Rating on Kymera Therapeutics (KYMR)
analyst Alex Thompson CFA maintained a Buy rating on Kymera Therapeutics (KYMR – Research Report) yesterday and set a price target of $68.00. The company's shares closed yesterday at $47.66. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Thompson CFA covers the Healthcare sector, focusing on stocks such as Kymera Therapeutics, Oruka Therapeutics, and Travere Therapeutics. According to TipRanks, Thompson CFA has an average return of -2.8% and a 45.45% success rate on recommended stocks. In addition to Stifel Nicolaus, Kymera Therapeutics also received a Buy from UBS's Eliana Merle in a report issued on June 3. However, on May 30, Bank of America Securities maintained a Hold rating on Kymera Therapeutics (NASDAQ: KYMR). The company has a one-year high of $53.27 and a one-year low of $19.45. Currently, Kymera Therapeutics has an average volume of 856.8K.
Yahoo
2 hours ago
- Yahoo
Car parts retailer Autodoc plans German IPO, bookrunner says
FRANKFURT (Reuters) -German online car parts retailer Autodoc intends to list on the Frankfurt Stock Exchange via a secondary share sale, a bookrunner on the initial public offering said on Friday. The Berlin-headquartered company's founders and the U.S. private equity firm Apollo Global Management will sell shares in the IPO. According to the bookrunner's document seen by Reuters, the offer structure is 100% secondary, indicating that the company will not receive any additional equity capital from new shares. The retailer, founded in Berlin in 2008, is active in 27 European countries. It mainly sells to consumers, but it is also increasingly targeting business clients, the document said. CITI, Barclays, Deutsche Bank and Jefferies have been mandated as joint global coordinators, according to the document.
